PC
BMY icon

Pier Capital’s Bristol-Myers Squibb BMY Stock Holding History

Pier Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-895
Closed -$48K – 141
2013
Q4 		$48K Buy
+895
New +$45.6K 0.01% 127
2013
Q3 		– Sell
-866
Closed -$39K – 141
2013
Q2 		$39K Buy
+866
New +$37.6K 0.01% 124

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pier Capital's BMY Position: Q1 2014 in Review

Pier Capital sold out of Bristol-Myers Squibb (BMY) in Q1 2014, closing a stake of 895 shares — an estimated $48K sold.

Pier Capital first reported a position in BMY in Q2 2013 and held it in 2 quarters. The position peaked at $48K in Q4 2013. 1,328 funds tracked by Wall St. Rank hold BMY as of Q1 2014.

  • Pier Capital reported no remaining Bristol-Myers Squibb position as of Q1 2014 after selling out during the quarter.
  • Pier Capital sold 895 Bristol-Myers Squibb shares in Q1 2014, an estimated $48K.
  • Pier Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 2 quarters.
  • Pier Capital's Bristol-Myers Squibb position peaked at $48K in Q4 2013.
  • 1,328 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2014.

Based on Pier Capital's 13F filing for Q1 2014, filed 13 May 2014.